SEGMENT REPORTING

12 Months Ended

Dec. 31, 2015

Segment Reporting [Abstract]

SEGMENT REPORTING

SEGMENT REPORTING

The Company is comprised of two reportable segments, Core Companion Animal Health ("CCA") and Other Vaccines, Pharmaceuticals and Products ("OVP"). The Core Companion Animal Health segment includes diagnostic instruments and supplies, as well as single use diagnostic and other tests, pharmaceuticals and vaccines, primarily for canine and feline use. The CCA segment also includes digital radiography and ultrasound products along with embedded software and support, data hosting and other services from Heska Imaging after February 24, 2013. These products are sold directly by the Company as well as through independent third-party distributors and through other distribution relationships. CCA segment products manufactured at the Des Moines, Iowa production facility included in the OVP segment's assets are transferred at cost and are not recorded as revenue for the OVP segment. The Other Vaccines, Pharmaceuticals and Products segment includes private label vaccine and pharmaceutical production, primarily for cattle, but also for other animals including small mammals. All OVP products are sold by third parties under third-party labels.

Summarized financial information concerning the Company's reportable segments is shown in the following table (in thousands):

Year Ended December 31, 2013	Core Companion Animal Health			Other Vaccines, Pharmaceuticals and Products		Total
Total revenue	$	66,404		$	11,935	$	78,339
Operating Income (loss)	(2,295		)	865		(1,430		)
Income (loss) before income taxes	(2,229		)	836		(1,393		)
Total assets	81,041			12,512		93,553
Net assets	36,933			10,183		47,116
Capital expenditures	512			1,418		1,930
Depreciation and amortization	1,691			806		2,497

Year Ended December 31, 2014	Core Companion Animal Health		Other Vaccines, Pharmaceuticals and Products		Total
Total revenue	$	72,354	$	17,483	$	89,837
Operating Income	1,198		1,713		2,911
Income before income taxes	1,290		1,660		2,950
Total assets	85,361		11,483		96,844
Net assets	41,286		11,846		53,132
Capital expenditures	1,864		473		2,337
Depreciation and amortization	2,954		758		3,712

Year Ended December 31, 2015	Core Companion Animal Health		Other Vaccines, Pharmaceuticals and Products		Total
Total revenue	$	84,249	$	20,348	$	104,597
Operating Income	4,911		3,646		8,557
Income before income taxes	4,836		3,591		8,427
Total assets	92,567		17,152		109,719
Net assets	48,175		15,353		63,528
Capital expenditures	1,177		2,596		3,773
Depreciation and amortization	3,478		709		4,187

Revenue is attributed to individual countries based on customer location. Total revenue by principal geographic area was as follows (in thousands):

	For the Years Ended December 31,
	2013		2014		2015
United States	$	71,713	$	83,584	$	97,164
Europe	2,738		2,264		2,086
Other International	3,888		3,989		5,347
Total	$	78,339	$	89,837	$	104,597

Total assets by principal geographic areas were as follows (in thousands):

	For the Years Ended December 31,
	2013		2014		2015
United States	$	90,572	$	93,977	$	106,780
Europe	2,981		2,867		2,939
Other International	—		—		—
Total	$	93,553	$	96,844	$	109,719